Analytical Data
-
基因名
S100A11
- Application
-
别名
ANXA1;ANX1;LPC1;Annexin A1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P31949
-
表达区间
1-105aa
-
氨基酸序列
MGSSHHHHHHSSGLVPRGSHMGSHMAKISSPTETERCIESLIAVFQKYAG KDGYNYTLSKTEFLSFMNTELAAFTKNQKDPGVLDRMMKKLDTNSDGQLD FSEFLNLIGGLAMACHDSFLKAVPSQKRT
-
分子量
14 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human NKX6-2 Protein，His
Cat：PA2000-9725
Recombinant Human S100A1 Protein，His
Cat：PA1000-2804
Recombinant Human EIF2C4 Protein，His
Cat：PA2000-1149
Protein Description
S100A11, a member of the S100 protein family, is a small calcium-binding protein known for its involvement in various cellular processes, including cell cycle regulation, differentiation, and inflammatory responses. This protein is primarily expressed in epithelial tissues, where it plays a crucial role in maintaining homeostasis and cellular communication. Research has shown that S100A11 is associated with a variety of pathological conditions, such as cancer, where its expression levels can correlate with tumor progression and metastasis. The recombinant version of S100A11 is increasingly being explored for its potential therapeutic applications due to its ability to modulate cellular signaling pathways. Moreover, studies indicate that S100A11 can influence the behavior of immune cells and has implications in autoimmune diseases, making it a target of interest in immunological research. The production of recombinant S100A11 provides valuable insights into its structural and functional characteristics, paving the way for developing novel diagnostic and therapeutic strategies.
